BioSpace News Archive

Business

Regeneron Reports Second Quarter 2021 Financial and Operating Results

Regeneron Pharmaceuticals, Inc. announced financial results for the second quarter of 2021 and provided a business update.

August 5, 2021
·
31 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) Significantly Prolonged Recurrence-Free Survival (RFS) Compared to Placebo as Adjuvant Therapy for Patients With Stage II Resected High-Risk Melanoma in Phase 3 KEYNOTE-716 Trial

Merck, known as MSD outside the United States and Canada, announced that the Phase 3 KEYNOTE-716 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, met its primary endpoint of recurrence-free survival for the adjuvant treatment of patients with surgically resected high-risk stage II melanoma.

August 5, 2021
·
41 min read
Business

ProQR Announces Second Quarter 2021 Operating and Financial Results

ProQR Therapeutics N.V., a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye diseases, reported its financial and operating results for the second quarter ended June 30, 2021, and provided a business update.

August 5, 2021
·
19 min read
Business

Atea Pharmaceuticals to Host Second Quarter Financial Results Conference Call on August 12, 2021

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that it will host a live conference call and audio webcast on Thursday, August 12, 2021 at 4:30 p.m. ET to report financial results for the second quarter ended June 30, 2021, and to provide a clinical and corporate update.

August 5, 2021
·
1 min read
Business

VBL Therapeutics to Report Second Quarter Financial Results on August 16

VBL Therapeutics will release its second quarter financial results for the period ended June 30, 2021 on Monday, August 16 before market open.

August 5, 2021
·
1 min read
Point-of-Care Glucose Testing Market | Increasing Investments towards the Development of the Healthcare Segment Drive the Market Growth

Point-of-care testing for glucose monitoring is a valuable tool for managing patients with diabetes in the outpatient settings.

August 5, 2021
·
3 min read
Optical Microscopes Segment Held the Dominant Share of 51.9% in the Life Science Microscopy Devices Market, Finds TMR

The demand within the global market for life science microscopy devices has been rising on account of advancements in the domain of medical research and development, finds Transparency Market Research.

August 5, 2021
·
4 min read
Business

Christopher Reidy Announces Intent to Retire from BD

BD, a leading global medical technology company, announced that Christopher Reidy, 64, executive vice president, chief financial officer and chief administrative officer, has informed the company of his intent to retire as he reaches retirement eligibility.

August 5, 2021
·
8 min read